Skip to main content
SpringerLink
Log in
SpringerLink
Log in

The Endocrine System

  • Chapter
Clinical Nuclear Medicine

Abstract

Although sonography (US) and cytology (fine-needle aspiration, FNA) play the principal role in the diagnosis of thyroid nodules, thyroid scintigraphy remains an important tool for guiding clinical decisions in thyroid diseases. Thyroid scintigraphy is so used in the diagnosis of the cause of a patient’s hyperthyroidism (Graves’ disease, thyroid autonomy, subacute, silent and post-partum thyroiditis, etc.), in the evaluation of selected patients with thyroid nodules and in the identification of normal and ectopic thyroid tissue (neonatal hypothyroidism).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akerström G, Malmaeus J, Bergström R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:14–21

    PubMed  Google Scholar 

  • Al Zahrani AA, Levine MA (1997) Primary hyperparathyroidism. Lancet 349:1233–1238

    PubMed  CAS  Google Scholar 

  • Al-Hawary MM, Francis IR, Korobkin M (2005) Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 19:277–292

    PubMed  Google Scholar 

  • Bardet S, et al. (1996) 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 44:587–596

    CAS  Google Scholar 

  • Becherer A, et al. (2004) Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 45:1161–1167

    PubMed  CAS  Google Scholar 

  • Becker D, Charles ND, Dworkin H, Hurley J, McDougall IR, Price D, Royal H, Sarkar S (1996) Procedure guideline for thyroid scintigraphy. J Nucl Med 37(7):1264–1266

    PubMed  CAS  Google Scholar 

  • Belhocine T, et al. (2002) Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 23:727–734

    PubMed  CAS  Google Scholar 

  • Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C, Sal-vetti A (2005) Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br J Cancer 92:1104–1109

    PubMed  CAS  Google Scholar 

  • Bilezikian JP, Potts JT, Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361 [review]

    PubMed  CAS  Google Scholar 

  • Blake MA, et al. (2006) Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy — initial experience. Radiology 238:970–977

    PubMed  Google Scholar 

  • Borley NR, Collins REC, O’Doherty M, Coakley A (1996) Technetium 99m-sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg 83:989–991

    PubMed  CAS  Google Scholar 

  • Bourguet P, et al. (2005) Understanding positron emission tomography (PET) with [18F]-FDG in clinical oncology. Information dedicated to patients and relatives. Bull Cancer 92:723–732

    PubMed  Google Scholar 

  • Carr CE, Cope C, Cohen DL, Fraker DL, Trerotola SO (2004) Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc IntervRadiol 15:1245–1250

    Google Scholar 

  • Cavalieri RR, McDougall IR (1996) In vivo isotopic tests and imaging. In: Braverman LE, Utiger RD (eds) Werner and Ingbar’s The Thyroid — A fundamental and clinical text, 7th edn. JB Lippincott-Raven, Philadelphia, pp 352–376

    Google Scholar 

  • Cescato R, et al. (2006) Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47:502–511

    PubMed  CAS  Google Scholar 

  • Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins REC (1989) 99mTc sestamibi — a new agent for parathyroid imaging. Nucl Med Commun 10:791–794

    Article  PubMed  CAS  Google Scholar 

  • Cook GJ, Wong JC, Smellie WJ, Young AE, Maisey MN, Fogel-man I (1998) [11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathy-roidism after surgery. Eur J Endocrinol 139:195–197

    PubMed  CAS  Google Scholar 

  • Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Man-del SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM (2006) The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1–33

    CAS  Google Scholar 

  • De Graaf JS, Dullaart RP, Kok T, Piers DA, Zwierstra RP (2000) Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. Eur J Surg 166:289–292

    PubMed  Google Scholar 

  • Dromain C, et al. (2005) Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23:70–78

    PubMed  Google Scholar 

  • Duet M, et al. (2003) Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. J Nucl Med 44:1767–1774

    PubMed  Google Scholar 

  • Fallo F, et al. (2006) Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91:454–459

    PubMed  CAS  Google Scholar 

  • Fuster D, Ybarra J, Ortin J, Torregrosa JV, Gilabert R, Setoain X, Paredes P, Duch J, Pons F (2006) Role of pre-operative imaging using (99m)Tc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 33:467–473

    PubMed  Google Scholar 

  • Gimenez-Roqueplo A, et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63:5615–5621

    PubMed  CAS  Google Scholar 

  • Giordano A, Rubello D, Casara D (2001) New trends in parathyroid scintigraphy. Eur J Nucl Med 28:1409–1420 [review]

    PubMed  CAS  Google Scholar 

  • Giovanella L (2005) Serum chromogranin — an assay in differential diagnosis of incidentally discovered adrenal masses. Anticancer Res 25(3A):1547–1550

    PubMed  Google Scholar 

  • Gotthardt M, et al. (2003) Influence of somatostatin receptor scintigraphy and CT-MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients. Digestion 68:80–85

    PubMed  CAS  Google Scholar 

  • Grumbach MM, et al. (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138:424–429

    PubMed  Google Scholar 

  • Haber RS, Kim CK, Inabnet WB (2002) Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 57:241–249

    Google Scholar 

  • Heath H, Hodgson SF, Kennedy MA (1980) Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 302:189–193

    Article  PubMed  Google Scholar 

  • Hegedus L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351:1764–1771

    PubMed  Google Scholar 

  • Hindié E, Melliere D, Perlemuter L, Jeanguillaume C, Galle P (1997) Primary hyperparathyroidism: Higher success rate of first surgery after preoperative Tc-99m-sestamibi/I-123 subtraction scanning. Radiology 204:221–228

    PubMed  Google Scholar 

  • Hindié E, Mellière D, Jeanguillaume C, Perlemuter L, Galle P (1998) Parathyroid imaging using simultaneous double-window recording of Tc-99m-sestamibi and 123I. J Nucl Med 39:1100–1105

    PubMed  Google Scholar 

  • Hindié E, Ureña P, Jeanguillaume C, et al. (1999) Preoperative imaging of parathyroid glands with technetium-99m-la-belled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 353:2200–2204

    PubMed  Google Scholar 

  • Hindie E, Melliere D, Jeanguillaume C, Urena P, de Labriolle-Vaylet C, Perlemuter L (2000) Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning. Arch Surg 135:1461–1468

    PubMed  CAS  Google Scholar 

  • Hoegerle S, et al. (2002) Pheochromocytomas: detection with 18F DOPA whole body PET — initial results. Radiology 222:507–512

    PubMed  Google Scholar 

  • Intenzo CM, Capuzzi DM, Jabbour S, et al. (2001) Scintigraphic features of autoimmune thyroiditis. Radiographics 21:957–964

    PubMed  CAS  Google Scholar 

  • Kaltsas, et al. (2001) Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86:895–902

    PubMed  CAS  Google Scholar 

  • Kettle AG, O’Doherty MJ (2006) Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med 36:206–211

    PubMed  Google Scholar 

  • Kraimps JL, Bouin-Pineau MH, Mathonnet M, De Calan L, Ronceray J, Visset J, Marechaud R, Barbier J (2000) Multicentre study of thyroid nodules in patients with Graves’ disease. Br J Surg 87:1111–1113

    PubMed  CAS  Google Scholar 

  • Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O (2006) Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 30:76–83

    PubMed  Google Scholar 

  • Krenning EP, et al. (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731

    PubMed  CAS  Google Scholar 

  • Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW (1993) Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20:283–292

    PubMed  CAS  Google Scholar 

  • Kwekkeboom DJ, Kooij PP, Bakker WH, Macke HR, Krenning EP (1999) Comparison of HlIn-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patient: biodistribution, kinetics, organ and tumor uptake. J Nucl Med 40: 762–767

    PubMed  CAS  Google Scholar 

  • Kwekkeboom DJ, et al. (2005) Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 23: 2754–2762

    PubMed  CAS  Google Scholar 

  • Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ (2001) Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med 28:478–482

    PubMed  Google Scholar 

  • Leboulleux S, et al. (2006) Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 91:920–925

    PubMed  CAS  Google Scholar 

  • Lebtahi R, et al. (1999) Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 40:1602–1608

    PubMed  CAS  Google Scholar 

  • Lee JA, Inabnet WB 3rd (2005) The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol 89:130–135 [review]

    PubMed  Google Scholar 

  • Levin KE, Clark OH (1989) The reasons for failure in parathyroid operations. Arch Surg 124:911–915

    PubMed  CAS  Google Scholar 

  • Lind P, Kohlfürst S (2006) Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 36: 194–205

    PubMed  Google Scholar 

  • Liu RC, Hill ME, Ryan JA, Jr (2005) One-gland exploration for mediastinal parathyroid adenomas: cervical and thoracoscopic approaches. Am J Surg 189:601–605

    PubMed  Google Scholar 

  • Lumachi F, et al. (2005) Role and cost-effectiveness of adrenal imaging and image-guided FNA cytology in the management of incidentally discovered adrenal tumours. Anticancer Res 25:4559–4562

    PubMed  Google Scholar 

  • Lundgren E, Rastad J, Thurfjell E, Akerström G, Ljunghall S (1997) Population-based screening for primary hyperpara-thyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287–294

    PubMed  CAS  Google Scholar 

  • Mamede M, et al. (2006) Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine-and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 27:31–36

    PubMed  Google Scholar 

  • Mann GN, et al. (2006) [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochro-mocytoma. Ann Surg Oncol 13:187–197

    PubMed  Google Scholar 

  • Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309–340

    PubMed  Google Scholar 

  • Martin D, Rosen IB, Ichise M (1996) Evaluation of single isotope technetium-99m-sestamibi in localization efficiency for hyperparathyroidism. Am J Surg 172:633–636

    PubMed  CAS  Google Scholar 

  • Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR, Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 17Suppl 2:N37–N43 [review]

    PubMed  CAS  Google Scholar 

  • Maurea S, Klain M, Caraco C, Ziviello M, Salvatore M (2002) Diagnostic accuracy of radionuclide imaging using 1311 nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. Nucl Med Commun 23:951–960

    PubMed  CAS  Google Scholar 

  • Meier DA, Kaplan MM (2001) Radioiodine uptake and thyroid scanning. Endocrinol Metab Clin North Am 30(2):291–313

    PubMed  CAS  Google Scholar 

  • Meller J, Becker W (2002) The continuing importance of thyroid scintigraphy in the era of high resolution ultra sound. Eur J Nucl Med Mol Imaging 29(Suppl 2):S425–S438

    Article  PubMed  Google Scholar 

  • Minn H, et al. (2004) Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 45:972–979

    PubMed  CAS  Google Scholar 

  • Molinari AS, Irvin GL, 3rd, Deriso GT, Bott L (1996) Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery 120:934–937

    PubMed  CAS  Google Scholar 

  • Mountz JM, et al. (1988) Scintigraphic localization of ovarian dysfunction. J Nucl Med 29:1644–1650

    PubMed  CAS  Google Scholar 

  • Mullan BP (2004) Nuclear medicine imaging of the parathyroid. Otolaryngol Clin North Am 37:909–939, xi-xii [review]

    PubMed  Google Scholar 

  • Muros MA, et al. (1998) 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma. Nucl Med Commun 19:735–742

    Article  PubMed  CAS  Google Scholar 

  • Nguyen C, et al. (2004) Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy. J Nucl Med 45:1660–1668

    PubMed  CAS  Google Scholar 

  • Nikou GC, et al. (2005) Gastrinornas associated with NEM-1 syndrome: new insights for the diagnosis and management in a series of 11 patients. Hepatogastroenterology 52:1668–1676

    PubMed  Google Scholar 

  • Nocaudie-Calzada M, Huglo D, Deveaux M, Carnaille B, Proye C, Marchandise X (1996) Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours. Eur J Nucl Med 23:1448–1454

    PubMed  CAS  Google Scholar 

  • Nocaudie-Calzada M, et al. (1999) Efficacy of iodine-131 6-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med 26:1326–1332

    PubMed  CAS  Google Scholar 

  • Orlefors H, et al. (2005) Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 90:3392–3400

    PubMed  CAS  Google Scholar 

  • Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK (2004) The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriamine-pentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab 89:2214–2221

    PubMed  CAS  Google Scholar 

  • Paganelli G, et al. (2001) Receptor-mediated radiotherapy with 90Y-DOTA-D-Phel-Tyr3-octreotide. Eur J Nucl Med 28: 426–434

    PubMed  CAS  Google Scholar 

  • Palestro CJ, Tomas MB, Tronco GG (2005) Radionuclide imaging of the parathyroid glands. Semin Nucl Med 35:266–276 [review]

    PubMed  Google Scholar 

  • Perie S, Fessi H, Tassart M, Younsi N, Poli I, St Guily JL, Talbot JN (2005) Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/ technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 45:344–352

    PubMed  Google Scholar 

  • Raderer M, et al. (2000) Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phel-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998. J Clin Oncol 18:1331–1336

    PubMed  CAS  Google Scholar 

  • Reubi JC, et al. (2000) Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 27:273–282

    PubMed  CAS  Google Scholar 

  • Reubi JC, Waser B, Schaer JC, Laissue JA (2001) Somatostatin reception sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 28(7):836-46. Erratum in: Eur J Nucl Med 2001;28:1433

    Google Scholar 

  • Ribeiro MJ, et al. (2005) Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 46:560–566

    PubMed  Google Scholar 

  • Rose B, et al. (2003) High-dose 1311-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 98:239–248

    PubMed  CAS  Google Scholar 

  • Rossi R, et al. (2000) Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440–1448

    PubMed  CAS  Google Scholar 

  • Rubello D, Pelizzo MR, Casara D (2003) Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. Eur J Nucl Med Mol Imaging 30:189–182

    Article  PubMed  Google Scholar 

  • Russell CF, Edis AJ (1982) Surgery for hyperparathyroidism: experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg 69:244–247

    PubMed  CAS  Google Scholar 

  • Safford SD, et al. (2004) Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer 101:1987–1993

    PubMed  CAS  Google Scholar 

  • Sarkar SD (2006) Benign thyroid disease: What is the role of nuclear medicine? Semin Nucl Med 36:185–193

    PubMed  Google Scholar 

  • Sawka AM, Gafni A, Thabane L, Young WF, Jr (2004) The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 89:2859–2866

    PubMed  CAS  Google Scholar 

  • Schillaci O, Massa R, Scopinaro F (2000) 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 41:459–462

    PubMed  CAS  Google Scholar 

  • Schillaci O, et al. (2003) Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med 44:359–368

    PubMed  CAS  Google Scholar 

  • Schoen EJ, Clapp W, To TT, Fireman BH (2004) The key role of newborn thyroid scintigraphy with isotopic iodide (1231) in defining and managing congenital hypothyroidism. Pediatrics 114(6):e683–e688

    PubMed  Google Scholar 

  • Seminara MD, Daniels GH (1998) Amiodarone and thyroid. Endocr Pract 4:48–54

    PubMed  CAS  Google Scholar 

  • Smith JR, Oates E (2004) Radionuclide imaging of the thyroid gland: patterns, pearls and pitfalls. Clin Nucl Med 29:181–193

    PubMed  Google Scholar 

  • Sosa JA, Powe NR, Levine MA, Udelsman R, Zeiger MA (1998) Profile of a clinical practice. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: A national survey of endocrine surgeons. J Clin Endocrinol Metab 83:2658–2665

    PubMed  CAS  Google Scholar 

  • Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E (2006) Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 202:423–430

    PubMed  Google Scholar 

  • Taillefer R, Boucher Y, Potvin C, Lambert R (1992) Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with Technetium-99m-Sestamibi (double-phase study). J Nucl Med 33:1801–1807

    PubMed  CAS  Google Scholar 

  • Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1–6

    PubMed  CAS  Google Scholar 

  • Thorin-Savoure A, et al. (2005) Collision/composite tumors of the adrenal gland: pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis. J Clin Endocrinol Metab 90:4924–4929

    PubMed  CAS  Google Scholar 

  • Unger N, et al. (2006) Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154:409–417

    PubMed  CAS  Google Scholar 

  • Utiger RD (1999) Treatment of primary hyperparathyroidism (editorial). N Engl J Med 341:13101–13102

    Google Scholar 

  • Valkema R, et al. (2005) Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0), Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate. J Nucl Med 46:83S–91S

    PubMed  CAS  Google Scholar 

  • Van der Harst E, et al. (2001) [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 86:685–693

    PubMed  Google Scholar 

  • Van Der Horst-Schrivers AN, Jager PL, Boezen HM, Schouten JP, Kema IP, Links TP (2006) Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas — experience and meta-analysis. Anticancer Res 26:1599–1604

    Google Scholar 

  • Waldherr C, et al. (2002) Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC. J Nucl Med 43:610–616

    PubMed  CAS  Google Scholar 

  • Weber CJ, Vansant J, Alazraki N (1993) Value of technetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery 114:1011–1018

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoires Cyclopharma, Biopôle Clermont-Limagne, 63360, Saint Beauzire, France

    Serge Askienazy MD, PhD

Authors
  1. E. Hindle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Calzada-Naucaudie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Serge Askienazy MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Straße 15, D-53127, Bonn, Germany

    Hans-Jürgen Biersack M.D. (Professor and Chairman) (Professor and Chairman)

  2. Nuclear Medicine and Radiology, Albert Einstein College of Medicine Director, Dept. of Nuclear Medicine Montefiore Medical Centre/Moses Division, 111 East 210th Street, Bronx, NY, 10467, USA

    Leonard M. Freeman M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hindle, E., Calzada-Naucaudie, M., Keller, I., Askienazy, S. (2007). The Endocrine System. In: Biersack, HJ., Freeman, L.M. (eds) Clinical Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28026-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-28026-2_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28025-5

  • Online ISBN: 978-3-540-28026-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation